Pharmafile Logo
- PMLiVE

Pharmaceutical Market Europe – January 2014

Sanofi’s SVP of corporate communications Laure Thibaud talks about her mission to build a communications team fit for the modern age

- PMLiVE

Pharmaceutical Market Europe – December 2013

The German HTA body’s drug assessment department head talks about taking a pragmatic approach to comparing medicines

- PMLiVE

Pharmaceutical Market Europe – November 2013

Lilly’s chief scientific officer for neurodegenerative diseases Dr Mike Hutton talks about the future for Alzheimer’s research

- PMLiVE

Pharmaceutical Market Europe – October 2013

Boehringer’s Allan Hillgrove talks access, partnerships and China

- PMLiVE

Pharmaceutical Market Europe – September 2013

Ariad’s Harvey Berger and Timothy Clackson discuss building a sustainable biotech business and following their own path

- PMLiVE

Pharmaceutical Market Europe – July/August 2013

Senior vice president of global research at UCB discusses the importance of patient-centricity, the value of collaboration and why full data transparency is problematic

- PMLiVE

Pharmaceutical Market Europe – June 2013

The chair of the UK’s NICE discusses navigating the stormy waters of health service reforms, collaborating with pharma and the introduction of value-based pricing

- PMLiVE

Pharmaceutical Market Europe – May 2013

Astellas’ vice president of marketing, Europe and its chief strategy officer, Europe discuss category leadership, the changing landscape of market access and growth in a time of austerity

- PMLiVE

Pharmaceutical Market Europe – April 2013

Managing director of Novo Nordisk UK, about how education and new partnerships are helping fight the battle against the country’s worsening diabetes crisis

- PMLiVE

Pharmaceutical Market Europe – March 2013

Senior vice president and head of Sanofi Diabetes discusses how the company is working to keep pace with the rapidly escalating threat from diabetes in emerging countries

- PMLiVE

Pharmaceutical Market Europe – February 2013

The BioIndustry Association CEO talks about the state of UK biotech, its shared ecosystem with the country’s pharmaceutical industry and the funding challenges biotech faces

- PMLiVE

Pharmaceutical Market Europe – December/January 2013

Janssen’s Cesar Rodriquez talks to PME, we look at pharma patents in India, industry prospects in Latin America and there’s a masterclass on custom valuation